Collating Considerations in the Development & Manufacturing of Long-Acting Injectables (LAIs)

Time: 9:45 am
day: Day One


  • Resolving formulation feasibility and delivery device selection issues toward product development
  • Establishing in vitro-in vivo relationship (IVIVR) for quality control of LAI dosage forms
  • Demonstrating bioequivalence of LAIs
  • Reflecting on market development challenges for long-acting injectable drug products